Category: PresentationsJune 18, 2016 Share this article Share on FacebookShare on Facebook TweetShare on Twitter Pin itShare on Pinterest Share on LinkedInShare on LinkedIn Share on WhatsAppShare on WhatsApp Author: Fenfuro Post navigationPreviousPrevious post:Abstract submission: ” Safety, efficacy and toxicological evaluation of a novel, patented anti-diabetic extract of trigonella foenum-graecum seed extract (fenfuro).”NextNext post:Abstract Submission: Safety, Efficacy And Toxicological Evaluation Of A Novel, Patented Anti-diabetic Extract Of Trigonella Foenum-graecum Seed Extract (Fenfuro)>You may also be interested in reading thesePoster Presentation on ‘Furocyst’ at FIGO, 2018October 16, 2018Fenfuro abstract selected for poster presentation at IDF 2018October 15, 20182nd position in poster presentation at International Conference on PCOSJune 19, 2017Abstract Submission: “Clinical Evaluation Of Standardized Fenugreek Seed Extract As Furostanolic Saponins (Furocyst) In Polycystic Ovary Syndome Patients.”June 18, 2016Abstract Submission: “Clinical Evaluation Fenugreek Seed Extract In Patients With Type-2 Diabetes: An Add-on Study In 154 Patients”June 18, 2016Abstract Submission: Safety, Efficacy And Toxicological Evaluation Of A Novel, Patented Anti-diabetic Extract Of Trigonella Foenum-graecum Seed Extract (Fenfuro)>June 18, 2016
Abstract Submission: “Clinical Evaluation Of Standardized Fenugreek Seed Extract As Furostanolic Saponins (Furocyst) In Polycystic Ovary Syndome Patients.”June 18, 2016
Abstract Submission: “Clinical Evaluation Fenugreek Seed Extract In Patients With Type-2 Diabetes: An Add-on Study In 154 Patients”June 18, 2016
Abstract Submission: Safety, Efficacy And Toxicological Evaluation Of A Novel, Patented Anti-diabetic Extract Of Trigonella Foenum-graecum Seed Extract (Fenfuro)>June 18, 2016
